Colorectal Cancer Surgery

Colorectal cancer surgery is the operative treatment of malignant tumours of the colon and rectum and is the cornerstone of cure for localized disease. Its principles are wide resection of the tumour-bearing segment with its draining lymphatic territory and restoration of bowel continuity where possible. Rectal cancer surgery in particular has been transformed by total mesorectal excision and by the integration of preoperative chemoradiotherapy, while laparoscopic access is now established for both colon and rectal resection.

Definition

Colorectal cancer surgery is the resection of a malignant tumour of the colon or rectum together with its regional lymphatic drainage, performed with the intent of cure or palliation, and including restoration of intestinal continuity or formation of a stoma.

Scope

This entry covers the oncological principles of resection for colon and rectal cancer, the central importance of total mesorectal excision for the rectum, the role of multimodal therapy combining surgery with radiotherapy and chemotherapy, and the evidence on minimally invasive access. It describes the field as a reference subject and does not provide staging, treatment selection, or other individualized clinical advice.

Core questions

• What defines an oncologically adequate resection of colon and rectal cancer?
• Why is total mesorectal excision central to rectal cancer surgery?
• How does preoperative chemoradiotherapy fit with surgery for rectal cancer?
• Is laparoscopic resection oncologically equivalent to open surgery?

Key concepts

• Oncological resection and lymphadenectomy
• Total mesorectal excision
• Circumferential resection margin
• Neoadjuvant chemoradiotherapy
• Anastomosis versus stoma
• Laparoscopic and minimally invasive access
• Sphincter preservation

Mechanisms

Cure of localized colorectal cancer depends on removing the primary tumour with adequate margins and the lymphatic field into which it drains, because regional nodes are the first route of spread; for the rectum, excising the mesorectum intact along an embryological plane (total mesorectal excision) minimizes a positive circumferential margin and local recurrence. Preoperative chemoradiotherapy can downstage rectal tumours and reduce local recurrence compared with postoperative treatment, which influences the timing of multimodal therapy relative to surgery (Sauer et al., 2004). Randomized trials established that laparoscopically assisted colectomy yields oncological outcomes comparable to open surgery for colon cancer (COST, 2004) and that laparoscopic resection is non-inferior for rectal cancer in terms of recurrence and survival in trial settings (Bonjer et al., 2015). Postoperative complications, including anastomotic leak, are graded by the Clavien-Dindo classification (Clavien et al., 2009).

Clinical relevance

Colorectal cancer surgery is a defining domain of general and colorectal surgery and a frequent subject of multidisciplinary cancer care, where surgical, oncological, and radiotherapy decisions interact. This entry is educational and descriptive and is not a basis for individual diagnosis, staging, or treatment decisions, which require qualified multidisciplinary assessment.

Epidemiology

Colorectal cancer is among the most commonly diagnosed cancers worldwide and a leading cause of cancer death, making resection one of the highest-volume major gastrointestinal cancer operations; outcomes are influenced by stage at presentation, completeness of resection, and increasingly by participation in screening programmes.

History

Modern rectal cancer surgery was reshaped by the description and dissemination of total mesorectal excision, which sharply reduced local recurrence by emphasizing precise dissection of the mesorectal envelope. In parallel, randomized trials in the early 2000s — the COST trial for colon cancer and the German Rectal Cancer Study for the sequencing of chemoradiotherapy — set the evidence base for laparoscopic resection and for preoperative multimodal therapy, and later trials such as COLOR II extended the evidence on minimally invasive rectal surgery.

Debates

Laparoscopic versus open resection for rectal cancer

Trials such as COLOR II support the oncological adequacy of laparoscopic rectal resection, but other randomized data raised concern about the completeness of the resected specimen, leaving the equivalence of minimally invasive rectal surgery a continuing point of discussion.

Key figures

• Bill Heald
• Rolf Sauer
• Hendrik Jaap Bonjer

Seminal works

• sauer-2004
• cost-2004
• bonjer-2015

Frequently asked questions

What is total mesorectal excision?

It is the surgical removal of the rectum together with the surrounding mesorectal fat and lymph nodes as an intact package along a natural anatomical plane, a technique that markedly reduces local recurrence of rectal cancer.

Is keyhole (laparoscopic) surgery used for colorectal cancer?

Yes. Randomized trials established laparoscopic colectomy as oncologically comparable to open surgery for colon cancer, and laparoscopic rectal resection is widely used, though debate about specimen quality in rectal cancer continues.